Ventana Medical Systems, Inc., will present recent advances in digital pathology multiplexing and algorithm assisted breast cancer testing at the Pathology Visions Conference in Baltimore October 28-31. Pascal Bamford, PhD, project lead for Ventana Multiplex and Molecular Assays, will present the key concepts of multiplexing gene and protein targets in tissue and discuss the importance and current challenges of translating this technology to the clinical setting. The multiplexing of genomic and proteomic targets in formalin-fixed, paraffin-embedded (FFPE) tissue is widely regarded as a key enabling technology in the future of personalized medicine and companion diagnostics. Gerardo Fernandez, MD, Medical Director for Digital Pathology at Ventana, will discuss the evolution of automated algorithmic analysis of the standard breast cancer immunohistochemistry (IHC) panel, from the pitfalls of early scoring techniques to the more robust late generation methods in use today.
In addition to sharing the latest advancements in digital pathology, Ventana will also present the latest versions of its Virtuoso digital pathology image and workflow management software and VANTAGE workflow solution for histology lab specimen tracking. Virtuoso 5.3, a web-based software, orchestrates the digital slide workflow from the moment the slide is scanned until the slide image is viewed and the case results reported. Ventana's newest scanner, the VENTANA iScan HT slide scanner, which is for Research Use Only in the United States and not for use in diagnostic procedures, will also be showcased. Learn more, with many useful links, including video presentations.
